Rie Baba
Overview
Explore the profile of Rie Baba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takaoka H, Kawada I, Hiruma G, Nagashima K, Terai H, Ishida N, et al.
BMJ Open Respir Res
. 2024 Dec;
11(1.
PMID: 39721744
Objectives: Severe acute respiratory syndrome coronavirus 2 significantly impacts Japan with a high number of infections and deaths reported. Long coronavirus disease (COVID) characterised by persistent symptoms after COVID-19 has...
2.
Yamagishi M, Miyata K, Kamatani T, Kabata H, Baba R, Tanaka Y, et al.
iScience
. 2024 May;
27(6):109840.
PMID: 38779479
Quantification of cytokine secretion has facilitated advances in the field of immunology, yet the dynamic and varied secretion profiles of individual cells, particularly those obtained from limited human samples, remain...
3.
4.
Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, et al.
Clin Transl Allergy
. 2024 Jan;
14(1):e12327.
PMID: 38282191
Background: Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most...
5.
Terai H, Ishii M, Takemura R, Namkoong H, Shimamoto K, Masaki K, et al.
Respir Investig
. 2023 Oct;
61(6):802-814.
PMID: 37783167
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly since 2019, and the number of reports regarding long COVID has increased. Although the distribution of long COVID depends...
6.
Baba R, Kabata H, Shirasaki Y, Kamatani T, Yamagishi M, Irie M, et al.
J Allergy Clin Immunol Glob
. 2023 Oct;
1(4):299-304.
PMID: 37779537
Background: Group 2 innate lymphoid cells (ILC2s) produce type 2 cytokines by stimulation with epithelial cell-derived cytokines and are implicated in the pathogenesis of various allergic diseases, including asthma. However,...
7.
Nakagawara K, Morita A, Namkoong H, Terai H, Chubachi S, Asakura T, et al.
Vaccine X
. 2023 Sep;
15:100381.
PMID: 37731516
We conducted a subgroup analysis of a study on the long-term effects of COVID-19 (long COVID) in Japan to assess the effect of vaccination on long COVID symptoms. We assessed...
8.
Yamamoto S, Yamayoshi S, Ito M, Sakai-Tagawa Y, Nakachi I, Baba R, et al.
iScience
. 2023 Jul;
26(7):107208.
PMID: 37448563
SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine efficacy. Here, we attempted to obtain mutant viruses...
9.
Tanaka H, Chubachi S, Namkoong H, Sato Y, Asakura T, Lee H, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad311.
PMID: 37441355
Background: To determine the effectiveness of baricitinib in patients with coronavirus disease 2019 (COVID-19), investigate whether baricitinib prevents the need for invasive mechanical ventilation and identify patient subgroups that would...
10.
Irie M, Kabata H, Sasahara K, Kurihara M, Shirasaki Y, Kamatani T, et al.
Cell Rep
. 2023 Jun;
42(6):112610.
PMID: 37294636
Group 2 innate lymphoid cells (ILC2s) produce large amounts of type 2 cytokines including interleukin-5 (IL-5) and IL-13 in response to various stimuli, causing allergic and eosinophilic diseases. However, the...